The company is making a shift to focus on only the highest-value GenAI use cases and shut down pilots that were redundant or ...

Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall ...

Analysts expect the New Brunswick, New Jersey-based company to report quarterly earnings at $2.58 per share, down from $2.71 ...

Healthcare giant Johnson & Johnson (JNJ)is gearing up to release its first-quarter 2025 financials on April 15. JNJ stock has gained over ...

The Dark Secrets of Johnson & Johnson.” Gardiner Harris, a former pharmaceutical reporter for The New York Times and a reporter for The Wall Street Journal, effectively explains the legal battles ...

Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain ...

Wall Street teetered toward small losses in relatively calm trading Tuesday morning after President Donald Trump appeared to ...

A Fox Business correspondent turned heads with a scoop about a possible tariff deal between the U.S. and India.

Mar Vista U.S. Quality Select Strategy stated the following regarding Johnson & Johnson (NYSE:JNJ) in its Q1 2025 investor ...

Johnson & Johnson shares dipped slightly today on first-quarter results and an update on the impact of tariffs.

U.S. stocks drifted through a rare quiet day for financial markets worldwide. The S&P 500 slipped 0.2% Tuesday.

Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year. The costs will be felt ...